Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06005480 · ClinicalTrials.gov registry record · Phase 1
Understanding Rebound Pain After Regional Anesthesia Resolution in Healthy Volunteers
A Phase 1 study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
NCT06005480 is a Phase 1 study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 40 participants.
The verdict
NCT06005480, a Phase 1 study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
Regional anesthesia decreases postoperative pain scores and opioid consumption, and may prevent chronic pain after surgery in patients undergoing surgery. However, some patients experience an increase of pain into the severe range when the nerve block wears off, also known as rebound pain. The investigators are studying if a nerve block (numbing injection) in the arm causes hyperalgesia (increased pain) when the nerve block is wearing off.
Interventions
- DRUG Mepivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-09-28 |
| Est. Completion | 2024-05-28 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06005480
The ClinicalTrials.gov registry entry for NCT06005480 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mepivacaine is the first listed.
NCT06005480 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06005480 about?
NCT06005480 is a clinical study titled "Understanding Rebound Pain After Regional Anesthesia Resolution in Healthy Volunteers". Regional anesthesia decreases postoperative pain scores and opioid consumption, and may prevent chronic pain after surgery in patients undergoing surgery. However, some patients experience an increase of pain into the severe range when the nerve block wears off, also known as rebound pain. The inves...
What is the current status of trial NCT06005480?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2023-09-28. Estimated completion is 2024-05-28.
What interventions are being tested in trial NCT06005480?
The interventions under investigation include: Mepivacaine (DRUG).
Who is sponsoring clinical trial NCT06005480?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.